Evidence map›Paper›PMID 42783422›Full record

Observational studyMedical sciences (Basel, Switzerland)2026

From Rapid Progression to Long-Lasting Complete Response: A Wide Range of Ripretinib Activity for Metastatic GIST-A Real-World Cohort.

Hanna T Frumin Edri, Walid Shalata, Ilia Berezhnov, Tanzila Tairov, Tatiana Bobrovitsky, Dan Mirelman, Esther Tahover, Ofer Purim, Yuval Dadon, Katerina Shulman and 4 more

Abstract readMulticenter StudyObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Medical sciences (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hanna T Frumin EdriOncology Institute, Edith Wolfson Medical Center, Holon 58220, Israel.
Walid ShalataLegacy Heritage Cancer Center, Soroka Medical Center, Beer Sheva 84105, Israel.ORCID 0000-0002-7570-4550
Ilia BerezhnovOncology Institute, Edith Wolfson Medical Center, Holon 58220, Israel.
Tanzila TairovOncology Institute, Edith Wolfson Medical Center, Holon 58220, Israel.
Tatiana BobrovitskyOncology Institute, Edith Wolfson Medical Center, Holon 58220, Israel.
Dan MirelmanTel Aviv Sourasky Medical Center, Tel Aviv 69978, Israel.
Esther TahoverTel Aviv Sourasky Medical Center, Tel Aviv 69978, Israel.
Ofer PurimHelmsley Cancer Center, Shaare Zedek Medical Center, Jerusalem 91031, Israel.
Yuval DadonOncology Institute, Edith Wolfson Medical Center, Holon 58220, Israel.ORCID 0009-0005-0556-335X
Katerina ShulmanCarmel Medical Center, Haifa 34362, Israel.
Gali PerlDavidoff Cancer Center, Rabin Medical Center, Petah Tikva 49414, Israel.
Gil Bar SelaTechnion Integrated Cancer Center, Faculty of Medicine, Technion, Haifa 31096, Israel.
Maria PasshakRambam Health Care Campus, Haifa 35254, Israel.ORCID 0009-0002-1670-1963
Ronen BrennerOncology Institute, Edith Wolfson Medical Center, Holon 58220, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gastrointestinal NeoplasmsGastrointestinal Stromal TumorsProtein Kinase InhibitorsAgedAged, 80 and overAntineoplastic AgentsCohort StudiesDisease ProgressionFemaleHumansMaleMiddle AgedMutationNaphthyridinesNeoplasm MetastasisProto-Oncogene Proteins c-kitAntineoplastic AgentsNaphthyridinesProtein Kinase InhibitorsProto-Oncogene Proteins c-kitripretinibUreaGISTKIT mutationreal-world evidenceripretinibswitch-control kinase inhibitor

Identifiers

PMID42783422
PMCPMC13609104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.